 |
|
|
| |
Why Do People With HIV Stop Long-Acting Injectable Cabotegravir-Rilpivirine and What Happens?
|
| |
| |
CROI 2025 SF March 9-12
Katerina Christopoulos1, Matt Hickey1, Janet Grochowski1, Francis Mayorga-Munoz1, Xavier Erguera1, Samantha Dilworth1, Elizabeth Imbert1, Ayesha Appa1, Matthew Spinelli1, Chesa Cox1, Mary Shiels1, Jon Oskarsson1, Monica Gandhi1 1University of California San Francisco, San Francisco, CA, USA
|
| |
|
|
|
|
|
